NIH-funded research R01 grant

Understanding immune responses and outcomes in acute pancreatitis

Official title: Immune Signatures and Clinical Outcomes in Acute Pancreatitis

Funded at Ohio State University · NIH-11083575 · Data updated 2026-11-12

This study is looking at how certain markers in the blood can help doctors predict which patients with acute pancreatitis might have a more severe illness, so they can provide better early treatment.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startApril 4, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$680,769
NIH project number5R01DK134698-03
Project IDNIH-11083575 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals admitted to the hospital with acute pancreatitis, particularly those at risk of developing severe disease.

Less likely to help

Patients with mild acute pancreatitis who are not at risk for severe complications may not benefit from this research.

What this research studies

This research investigates how immune signatures can predict clinical outcomes in patients with acute pancreatitis (AP). By analyzing blood samples from patients, the study aims to identify specific cytokine profiles that can indicate which patients are likely to develop severe forms of the disease. The approach involves a multi-center, observational cohort design, allowing for a diverse patient population and robust data collection. The ultimate goal is to improve early prediction and treatment strategies for patients suffering from acute pancreatitis.

Why it matters

Potential benefit: If successful, this research could lead to better prediction tools and targeted therapies for patients with acute pancreatitis, potentially reducing hospital stays and improving survival rates.

How similar studies have gone: Previous research has shown promise in using immune signatures for predicting outcomes in other conditions, suggesting that this approach may also be effective in acute pancreatitis.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Papachristou, Georgios I — Ohio State University
  • Study coordinator: Papachristou, Georgios I

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.